[HTML][HTML] Pharmacological-and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults

GC Leitner, H Vogelsang - World journal of gastrointestinal …, 2016 - ncbi.nlm.nih.gov
Inflammatory bowel diseases (IBDs) are a group of chronic inflammatory conditions mainly
of the colon and small intestine. Crohn's disease (CD) and ulcerative colitis (UC) are the …

Pharmacotherapeutical options in inflammatory bowel disease: an update

YH Kho, M Oudkerk Pool, FGA Jansman… - Pharmacy World and …, 2001 - Springer
Chronic inflamatory bowel disease (IBD) refers to two diseases: Crohn's disease (CD) and
ulcerative colitis (UC). The etiology of IBD remains unknown. The understanding of the …

Pharmacological therapy in inflammatory bowel diseases: a narrative review of the past 90 years

M Imbrizi, F Magro, CSR Coy - Pharmaceuticals, 2023 - mdpi.com
Inflammatory Bowel Diseases had their first peak in incidence in countries in North America,
Europe, and Oceania and are currently experiencing a new acceleration in incidence …

[PDF][PDF] Biological therapy of inflammatory bowel disease

D Owczarek, D Cibor, M Szczepanek… - … = Polish Archives of …, 2009 - ruj.uj.edu.pl
AbstrAct Ulcerative colitis (UC), Crohn's disease (CD) and indeterminate colitis are defined
as inflammatory bowel diseases (IBD). Those diseases involve disorders of numerous …

Emerging therapies for inflammatory bowel disease

R Weisshof, K El Jurdi, N Zmeter, DT Rubin - Advances in therapy, 2018 - Springer
Inflammatory bowel disease (IBD) is a chronic heterogeneous group of diseases that has
undergone major advances in the understanding of its etiology and pathogenesis in recent …

Inflammatory bowel disease: etiology, pathogenesis and current therapy

JK Ko, KK Auyeung - Current pharmaceutical design, 2014 - ingentaconnect.com
Ulcerative colitis (UC) and Crohn's disease (CD) constitute the two major groups of
idiopathic disorders in inflammatory bowel disease (IBD). Environmental factors, genetic …

Treatment of inflammatory bowel disease: a comprehensive review

Z Cai, S Wang, J Li - Frontiers in medicine, 2021 - frontiersin.org
Inflammatory bowel disease (IBD), as a global disease, has attracted much research
interest. Constant research has led to a better understanding of the disease condition and …

[HTML][HTML] New trends in inflammatory bowel disease

C Palmela, J Torres, M Cravo - GE Portuguese journal of gastroenterology, 2015 - Elsevier
Inflammatory bowel disease (IBD) is a chronic idiopathic inflammatory disease of the
gastrointestinal (GI) tract. In the past decade a shift in the treatment paradigm of IBD has …

Conventional drug therapy for inflammatory bowel disease

RV Bryant, O Brain, SPL Travis - Scandinavian journal of …, 2015 - Taylor & Francis
Most patients with inflammatory bowel diseases (IBD) are offered conventional medical
therapy, because emerging therapies for IBD are regulated by health-care jurisdiction and …

[HTML][HTML] Treatment strategies in inflammatory bowel diseases

A Stallmach, R Atreya, PC Grunert… - Deutsches Ärzteblatt …, 2023 - ncbi.nlm.nih.gov
Background The prevalence of inflammatory bowel disease (IBD) is rising globally. In
Germany, these conditions affect 0.7% of the population, or approximately 600 000 patients …